CME Group price target raised to $263 from $257 at Barclays

Barclays raised the firm’s price target on CME Group (CME) to $263 from $257 and keeps an Equal Weight rating on the shares following the Q4 report. CME’s earnings beat Street estimates by 3%, as revenues beat by ~1%, slightly offset by adjusted spending which came in 2% ahead, the analyst tells investors in a research note.